Back to Trades
GORDON CARL L
Director10% OwnerCIK 0001282930
Profile
- Filings
- 11
- Buy transactions
- 7
- Sell transactions
- 0
- Companies
- 5
- Active
- 2025–2026
Across 11 filings between 2025–2026, GORDON CARL L, Director, 10% Owner, has disclosed $65.6M in transactions — spread across 5 companies. Their disclosed trades are heavily weighted toward buying — $61.1M in buys and $0 in sells. The largest single open-market purchase on record is $20.0M in Electra Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Sep 30 | ADRX ADARx Pharmaceuticals, Inc. | GORDON CARL L | Director, 10% Owner | Buy | $16.1M |
| Sep 24 | ADRX ADARx Pharmaceuticals, Inc. | GORDON CARL L | Insider | Other | $0 |
| Sep 23 | ETRA Electra Therapeutics, Inc. | GORDON CARL L | Director, 10% Owner | Buy | $20.0M |
| Sep 18 | ETRA Electra Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Aug 12 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Director | Buy | $10.0M |
| Aug 10 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Insider | Award | $382.5K |
| Aug 6 | BLSM BlossomHill Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Jul 29 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Director | Buy | $15.0M |
| Jul 27 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Award | $220.9K |
| Jul 23 | SCTX Scribe Therapeutics, Inc. | GORDON CARL L | Insider | Other | $0 |
| Dec 18 | KROS Keros Therapeutics, Inc. | GORDON CARL L | Director | Disposed | $3.8M |
11 filings